MedTrace Logo

Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up

NCT05586204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154977

Last updated 2024-12-09

No results posted yet for this study

Summary

This is a prospective randomized clinical trial evaluating how behaviorally-informed outreach text messages affect the take-up of bivalent COVID-19 booster. The investigators will test the impact of sending text reminders as well as the importance of elevating vaccination intentions, facilitating action, and their combination.

Conditions

Interventions

BEHAVIORAL

Eligibility reminder

Patients will receive a reminder of their eligibility for the bivalent COVID-19 booster

BEHAVIORAL

Link to a narrow set of vaccine venues

The reminder will encourage people to claim their dose today by booking an appointment. It will contain a link to schedule a booster appointment at UCLA Health and a link to CVS pharmacy

BEHAVIORAL

Link to a broad set of vaccine venues

The reminder will encourage people to claim their dose today by booking an appointment. It will contain a link to schedule a booster appointment at UCLA Health and a link to vaccine.gov (where people can find a wide set of local pharmacies that carry the bivalent booster).

BEHAVIORAL

Doctors' recommendation and value of vaccine

The reminder will contain information about the value of the bivalent booster and doctors' recommendation to get it

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-18
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05586204 on ClinicalTrials.gov